About the Product

Description


Zuclosol 50 Injection containing Zuclopenthixol is used for the management of psychiatric and behavioral disorders. It helps improve mental balance and supports emotional stability.

Zuclopenthixol works as an antipsychotic agent that helps regulate neurotransmitter activity in the brain, thereby supporting better behavioral and psychological control.

The injection is widely prescribed in psychiatry and neuro care practice for long-term psychiatric condition management, leading to consistent prescription demand.

With increasing awareness regarding mental health and psychiatric care, this product offers strong business potential for retailers and distributors. Its established antipsychotic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the CNS care segment.

Some patients may experience drowsiness, dizziness, dry mouth, tremors, muscle stiffness, restlessness, or weight gain. Rarely, severe movement disorders, allergic reactions, or cardiovascular complications may occur and require immediate medical attention.

Zuclosol 50 Injection is indicated for schizophrenia, psychosis, agitation, aggressive behavior, and other chronic psychiatric disorders as advised by a healthcare professional. It helps reduce hallucinations, disturbed thinking, restlessness, and emotional instability.

This injection should be administered strictly under medical supervision by qualified healthcare professionals. Regular monitoring may be required during treatment. Avoid alcohol consumption and use cautiously in patients with heart disease, epilepsy, liver disorders, or Parkinson’s disease.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the ampoule in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Zuclopenthixol 50mg Injection in the PCD pharma franchise market?

Zuclopenthixol 50mg Injection has strong demand in the psychiatry, hospital care, and specialty medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric and specialty injectable portfolios.

Why should medical distributors include Zuclopenthixol 50mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for psychiatric disorder management under specialist medical supervision. Zuclopenthixol 50mg is a typical antipsychotic medication used in the management of various psychiatric conditions Commonly prescribed for schizophrenia, psychotic disorders, agitation, behavioral disturbances, and other severe mental health conditions as determined by psychiatrists The injectable formulation provides an effective option for patients requiring parenteral treatment and supervised administration Frequently used in psychiatric hospitals, specialty clinics, and healthcare institutions Widely prescribed by psychiatrists and mental health specialists This strengthens a comprehensive psychiatry and specialty injectable portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Zuclopenthixol 50mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialist prescription demand, institutional procurement opportunities, repeat orders from psychiatric care centers, reliable supply chain support, and attractive margins in the neuropsychiatric segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.